Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide

Background: Enzalutamide is useful for the treatment of castration-resistant prostate cancer (CRPC). Despite its usefulness, adverse events (AEs) sometimes force patients to discontinue treatment. To maximize patient care, we developed an ambulatory care pharmacy practice that allows collaboration b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirabatake, Masaki, Ikesue, Hiroaki, Iwama, Yuna, Irie, Kei, Yoshino, Shintaro, Yamasaki, Toshinari, Hashida, Tohru, Kawakita, Mutsushi, Muroi, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162505/
https://www.ncbi.nlm.nih.gov/pubmed/35662711
http://dx.doi.org/10.3389/fphar.2022.901099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162505/
https://www.ncbi.nlm.nih.gov/pubmed/35662711
http://dx.doi.org/10.3389/fphar.2022.901099

Ejemplares similares